San Francisco, California, United States In 2011 was created Good Ventures, which is appeared as VC. The main office of represented VC is situated in the San Francisco. The fund was located in North America if to be more exact in United States.
Among the most popular portfolio startups of the fund, we may highlight Vicarious. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Software, Information Services.
This organization was formed by Dustin Moskovitz. Besides them, we counted 2 critical employees of this fund in our database.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2014. Considering the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 9-10 participants. Despite the Good Ventures, startups are often financed by Founders Fund, Felicis Ventures, Open Field Capital. The meaningful sponsors for the fund in investment in the same round are Founders Fund, Felicis Ventures, Open Field Capital. In the next rounds fund is usually obtained by Khosla Ventures, Samsung NEXT, Pegasus Tech Ventures.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Alopexx Enterprises | Concord, Massachusetts, United States |
| Beijing Tongxing Lian Touzi Guanli | Beijing, Beijing, China |
| Bioclub | China, Hangzhou, Zhejiang |
| CBC Co | - |
| Central Wisconsin Angel Investors | Madison, United States, Wisconsin |
| Guangzhou Boshi Touzi Guanli Youxian Gongsi | China, Guangdong, Guangzhou |
| Huddle | Haryana, Haryana, India |
| MyBey Ventures | - |
| Oaktree Specialty Lending Corp. | New York, United States, White Plains |
| PLG Ventures | California, Santa Monica, United States |
| Shanhua Touzi | China, Guangdong, Guangzhou |
| SINOCHEM GROUP | Beijing, Beijing, China |
| Taiwan Development Fund | - |
| Tertium Technology | Bengaluru, India, Karnataka |
| TIAN JIAN | Beijing, Beijing, China |
| Tier IV | - |
| Valneva | France, Pays de la Loire, Saint-herblain |
| Vidici Ventures | Stockholm, Stockholm County, Sweden |
| Wasted Talent | British Columbia, Canada, Vancouver |
| Weintraub Capital Management | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
VenomAid Diagnostics | $800K | 29 Jan 2024 | Kongens Lyngby, Hovedstaden, Denmark | ||
VenomAid Diagnostics | $1M | 25 Jan 2023 | Kongens Lyngby, Hovedstaden, Denmark | ||
New Leaf Dynamic Technologies | $799K | 15 Sep 2022 | New Delhi, Delhi, India | ||
Greenleaf Technologies | $933K | 19 Apr 2022 | Covington, Louisiana, United States | ||
Sherlock Biosciences | $80M | 08 Mar 2022 | Cambridge, Massachusetts, United States | ||
Kainomyx | 01 Jan 2022 | Palo Alto, California, United States | |||
Unravel Biosciences | $1M | 10 Oct 2021 | Boston, Massachusetts, United States | ||
Olilux Biosciences | 01 Jan 2021 | Wilmington, Delaware, United States | |||
VasoRx | 01 Nov 2020 | Santa Barbara, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
VenomAid Diagnostics | $800K | 29 Jan 2024 | Kongens Lyngby, Hovedstaden, Denmark | ||
VenomAid Diagnostics | $1M | 25 Jan 2023 | Kongens Lyngby, Hovedstaden, Denmark | ||
New Leaf Dynamic Technologies | $799K | 15 Sep 2022 | New Delhi, Delhi, India | ||
Greenleaf Technologies | $933K | 19 Apr 2022 | Covington, Louisiana, United States | ||
Sherlock Biosciences | $80M | 08 Mar 2022 | Cambridge, Massachusetts, United States | ||
Kainomyx | 01 Jan 2022 | Palo Alto, California, United States | |||
Unravel Biosciences | $1M | 10 Oct 2021 | Boston, Massachusetts, United States | ||
Olilux Biosciences | 01 Jan 2021 | Wilmington, Delaware, United States | |||
VasoRx | 01 Nov 2020 | Santa Barbara, California, United States |
